SE9704463D0 - Novel auto antigen - Google Patents

Novel auto antigen

Info

Publication number
SE9704463D0
SE9704463D0 SE9704463A SE9704463A SE9704463D0 SE 9704463 D0 SE9704463 D0 SE 9704463D0 SE 9704463 A SE9704463 A SE 9704463A SE 9704463 A SE9704463 A SE 9704463A SE 9704463 D0 SE9704463 D0 SE 9704463D0
Authority
SE
Sweden
Prior art keywords
relates
tryptophan hydroxylase
kit
autoimmune
novel auto
Prior art date
Application number
SE9704463A
Other languages
Swedish (sv)
Inventor
Olov Ekvall
Fredrik Rorsman
Olle Kaempe
Original Assignee
Olov Ekvall
Fredrik Rorsman
Olle Kaempe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olov Ekvall, Fredrik Rorsman, Olle Kaempe filed Critical Olov Ekvall
Priority to SE9704463A priority Critical patent/SE9704463D0/en
Publication of SE9704463D0 publication Critical patent/SE9704463D0/en
Priority to AU15168/99A priority patent/AU1516899A/en
Priority to PCT/SE1998/002171 priority patent/WO1999028753A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a reagent and kit for assaying antibodies against a novel autoantigen, tryptophan hydroxylase. The kit is especially suited for diagnosis of gastrointestinal dysfunction, e.g. in APS I (autoimmune polyendocrine syndrome, type I) patients. Furthermore, the invention relates to tryptophan hydroxylase as a drug target in the production of drugs for the treatment of autoimmune diseases. The invention also relates to a method for treating patients having an autoimmune disease. The method is characterized by the administration of a drug interacting with tryptophan hydroxylase or parts thereof.
SE9704463A 1997-11-28 1997-11-28 Novel auto antigen SE9704463D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9704463A SE9704463D0 (en) 1997-11-28 1997-11-28 Novel auto antigen
AU15168/99A AU1516899A (en) 1997-11-28 1998-11-27 Application of tryptophan hydroxylase, a novel autoantigen, in immunoassays, drug production and treatment
PCT/SE1998/002171 WO1999028753A1 (en) 1997-11-28 1998-11-27 Application of tryptophan hydroxylase, a novel autoantigen, in immunoassays, drug production and treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704463A SE9704463D0 (en) 1997-11-28 1997-11-28 Novel auto antigen

Publications (1)

Publication Number Publication Date
SE9704463D0 true SE9704463D0 (en) 1997-11-28

Family

ID=20409209

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704463A SE9704463D0 (en) 1997-11-28 1997-11-28 Novel auto antigen

Country Status (3)

Country Link
AU (1) AU1516899A (en)
SE (1) SE9704463D0 (en)
WO (1) WO1999028753A1 (en)

Also Published As

Publication number Publication date
WO1999028753A1 (en) 1999-06-10
AU1516899A (en) 1999-06-16

Similar Documents

Publication Publication Date Title
DE69922261D1 (en) MONOCLONAL ANTIBODIES, ANTIGENS AND DIAGNOSIS AND THERAPY OF VICIOUS DISEASES
EA200700083A1 (en) ANTIBODIES DIRECTED AGAINST BETA AMYLOID PEPTIDE, AND METHODS OF THEIR APPLICATION
JP2005506947A5 (en)
DE60235746D1 (en) Antibody to Alzheimer specific tau proteins with abnormal conformation
ES2120416T3 (en) TUMOR GROWTH INHIBITORS DERIVED FROM TISSUES, PREPARATION METHODS AND USES OF THESE INHIBITORS.
BR0206160A (en) Use of anti-TNF antibodies as medicines in the treatment of septic disorders of anemic patients.
RU2005134354A (en) ANTIBODIES AGAINST MONOCITARY CHEMOATTRACTANT, PROTEIN-1, (MCP-1) AND THEIR APPLICATION
Shmuel‐Galia et al. Neutralization of pro‐inflammatory monocytes by targeting TLR2 dimerization ameliorates colitis
BRPI0510883A (en) conjugated drug and antibody compound, pharmaceutical composition, cell proliferation inhibition methods, cancer treatment, tumor cell growth inhibition and dysfunction-sensitive human patient treatment, cancer cell detection test, industrialized article and method drug and antibody conjugate manufacturing
MA29346B1 (en) Gastroresistant pharmaceutical formulations based on rifaximin
EA200801071A1 (en) METHODS AND COMPOSITIONS FOR APPLICATION FOR THE TREATMENT OF PATIENTS WITH POSITIVE ON AUTOANTIBODIES DISEASE
HUP0102193A2 (en) Glucagon-like peptide-1 improves betha-cell response to glucose in subjects with impaired glucose tolerance
DE69010206D1 (en) STABILIZED PROTEIN OR PEPTIDE CONJUGATES.
ATE493978T1 (en) TREATMENT OF AUTOIMMUNE DISEASES
DE59705683D1 (en) IMMUNOLOGICAL DETECTION METHOD OF ANTIBODIES TARGETED AGAINST TISSUE TRANSGLUTAMINASE (tTG), USE OF tTG FOR DIAGNOSIS AND THERAPY CONTROL, AND ORAL PHARMACEUTICAL AGENT CONTAINING tTG
EP2147928A3 (en) Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
WO2001054681A8 (en) Composition for treatment of stress
NZ542866A (en) Compositions and methods for the therapy of inflammatory bowel disease
JP2004538477A5 (en)
DE60129278D1 (en) Antibodies directed against the SEMP1 protein, process for their preparation, and their uses
MA30665B1 (en) TREATMENT OF RHEUMATOID DISEASES WITH DELAYED RELEASE GLUCOCORTICOIDS.
SE9704463D0 (en) Novel auto antigen
WO2002094199A3 (en) METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
Parker et al. Allergic drug responses-mechanisms and unsolved problems
WO2005097183A3 (en) Treatment of diseases